Market Capitalization (Millions $) |
1,100 |
Shares
Outstanding (Millions) |
41 |
Employees |
- |
Revenues (TTM) (Millions $) |
145 |
Net Income (TTM) (Millions $) |
-164 |
Cash Flow (TTM) (Millions $) |
167 |
Capital Exp. (TTM) (Millions $) |
15 |
Mirum Pharmaceuticals Inc
Mirum Pharmaceuticals Inc. is a biopharmaceutical company that focuses on the development and commercialization of therapies for patients with rare liver diseases. The company is dedicated to improving the lives of patients by advancing innovative treatments that address unmet medical needs. Mirum Pharmaceuticals is known for its expertise in developing therapies that target rare diseases like Alagille syndrome, progressive familial intrahepatic cholestasis, and bile acid synthesis disorders. The company aims to provide effective and safe treatments for patients suffering from these rare liver diseases, ultimately improving their quality of life.
Company Address: 950 Tower Lane, Suite 1050, Foster City 94404 CA
Company Phone Number: 667-4085 Stock Exchange / Ticker: NASDAQ MIRM
|